サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1605868

創薬AI市場、規模、シェア、動向、産業分析レポート：提供別、技術別、治療領域別、用途別、エンドユーザー別、地域別 - 市場予測 2025年～2034年

AI in Drug Discovery Market Size, Share, Trends, Industry Analysis Report: By Offering, By Technology, By Therapeutic Area, By Application, By End User, and By Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 120 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
創薬AI市場、規模、シェア、動向、産業分析レポート：提供別、技術別、治療領域別、用途別、エンドユーザー別、地域別 - 市場予測 2025年～2034年
出版日: 2024年11月01日
発行: Polaris Market Research
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、創薬AI市場規模は2034年までに264億9,779万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

創薬AI市場は、技術進歩の急速な採用、ヘルスケアニーズの増加、製薬業界のダイナミクスの進化により、急速な成長を遂げています。より効率的で費用対効果の高い医薬品開発プロセスに対する需要の高まりが、創薬AI市場の需要を促進しています。従来の創薬手法は時間とコストがかかることが多く、臨床試験中の失敗率も高いです。AIは、潜在的な医薬品候補の特定、有効性と安全性の予測、臨床試験デザインの最適化を加速することで解決策を提供します。これにより、医薬品開発に関連する時間とコストが削減され、市場開拓に貢献します。さらに、慢性疾患の蔓延と個別化医療のニーズの高まりが、創薬ソリューションにおけるAIの需要を促進しています。高齢化が進み、がん、糖尿病、心血管疾患などの罹患率が上昇する中、より効果的な新しい治療法のニーズが高まっています。機械学習や深層学習を含むAI技術は、大規模なデータセットを分析し、従来の手法では明らかにならないパターンを特定するのに特に適しています。この能力により、個々の患者のプロファイルに合わせた標的治療の開発が可能になり、治療成績の向上や副作用の軽減が期待できます。

創薬AIの導入は、官民双方からの多額の投資によって促進されています。世界中の政府やヘルスケア機関は、創薬プロセスに革命をもたらすAIの可能性を認識し、イノベーションを促進するための研究開発イニシアチブに投資しています。さらに、AI技術企業と製薬大手とのコラボレーションも増加しており、医薬品開発のさまざまな段階にAIを統合することを目的としたパートナーシップが結ばれています。こうした協力関係はさらに、計算能力、クラウドコンピューティング、ビッグデータ解析の進歩によって支えられており、これらは創薬AIアプリケーションに必要なインフラを提供しています。

創薬AI市場レポートハイライト

2024年、革新的ながん治療に対する高い需要と、AI主導型ソリューションから大きな恩恵を受けるがん研究の複雑性により、創薬AI市場において腫瘍学セグメントが最大の売上シェアを占めました。

製薬・バイオテクノロジー企業セグメントは、創薬を加速し、開発コストを削減し、医薬品開発プロセスの精度と効率を高めるためにAI技術の採用を増やしていることから、最も速いCAGRで成長すると予測されています。

2024年には、北米が創薬AI市場で最大の市場シェアを占めたが、これは高度なヘルスケアインフラ、AI研究への高水準の投資、医薬品開発にAIを活用する大手製薬・バイオテクノロジー企業の存在によるものです。

アジア太平洋地域は、大規模で多様な患者集団が貴重なデータを提供していること、創薬のイノベーションを促進する政府の支援策があることから、予測期間中に最も速いCAGRで成長すると予想されます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 創薬AI市場の世界な洞察

  • アプリケーションスナップショット
  • 創薬市場力学
    • 促進要因と機会
      • 製薬会社とAIプロバイダーの連携が市場の成長を牽引
      • AIテクノロジーの進歩が市場の成長を促進しています。
    • 抑制要因と課題
      • データのプライバシーとセキュリティに関する懸念が、創薬AI市場の成長を制限している
  • PESTEL分析
  • 創薬市場におけるAIの応用動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 創薬AI市場の世界的動向：提供別

  • 主な調査結果
  • イントロダクション
  • ソフトウェア
  • サービス

第6章 世界の創薬AI市場：技術別

  • 主な調査結果
  • イントロダクション
  • 機械学習
  • その他のテクノロジー

第7章 世界の創薬AI市場：治療領域別

  • 主な調査結果
  • イントロダクション
  • 腫瘍学
  • 神経変性疾患
  • 心血管疾患
  • 代謝性疾患
  • 感染症
  • その他

第8章 世界の創薬AI市場：用途別

  • 主な調査結果
  • イントロダクション
  • 医薬品の最適化と再利用
  • 前臨床試験
  • その他

第9章 世界の創薬AI市場：エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 製薬・バイオテクノロジー企業
  • 契約調査機関
  • 研究センター
  • 学術機関および政府機関

第10章 世界の創薬AI市場：地域別

  • 主な調査結果
  • イントロダクション
    • 創薬AI市場評価：地域別、2020～2034年
  • 北米
    • 北米：提供別、2020～2034年
    • 北米：技術別、2020～2034年
    • 北米：治療領域別、2020年～2034年
    • 北米：用途別、2020～2034年
    • 北米：エンドユーザー別、2020～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：提供別、2020～2034年
    • 欧州：技術別、2020～2034年
    • 欧州：治療領域別、2020～2034年
    • 欧州：用途別、2020～2034年
    • 欧州：エンドユーザー別、2020～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋地域：提供別、2020年～2034年
    • アジア太平洋地域：技術別、2020～2034年
    • アジア太平洋地域：治療領域別、2020年～2034年
    • アジア太平洋地域：用途別、2020～2034年
    • アジア太平洋地域：エンドユーザー別、2020～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：提供別、2020～2034年
    • 中東・アフリカ：技術別、2020～2034年
    • 中東・アフリカ：治療領域別、2020～2034年
    • 中東・アフリカ：用途別、2020～2034年
    • 中東・アフリカ：エンドユーザー別、2020～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：提供別、2020～2034年
    • ラテンアメリカ：技術別、2020～2034年
    • ラテンアメリカ：治療領域別、2020～2034年
    • ラテンアメリカ：用途別、2020～2034年
    • ラテンアメリカ：エンドユーザー別、2020～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第11章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第12章 企業プロファイル

  • Atomwise Inc.
  • BenevolentAI
  • Berg Health
  • BioSymetrics, Inc.
  • CYCLICA
  • Exscientia
  • GNS Healthcare
  • Google
  • IBM
  • Insilico Medicine
  • insitro
図表

List of Tables:

  • Table 1 Global AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 2 Global AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 3 Global AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 4 Global AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 5 Global AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 6 North America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 7 North America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 8 North America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 9 North America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 10 North America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 11 U.S.: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 12 U.S.: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 13 U.S.: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 14 U.S.: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 15 U.S.: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 16 Canada: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 17 Canada: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 18 Canada: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 19 Canada: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 20 Canada: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 21 Europe: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 22 Europe: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 23 Europe: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 24 Europe: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 25 Europe: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 26 UK: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 27 UK: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 28 UK: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 29 UK: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 30 UK: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 31 France: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 32 France: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 33 France: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 34 France: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 35 France: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 36 Germany: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 37 Germany: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 38 Germany: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 39 Germany: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 40 Germany: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 41 Italy: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 42 Italy: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 43 Italy: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 44 Italy: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 45 Italy: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 46 Spain: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 47 Spain: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 48 Spain: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 49 Spain: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 50 Spain: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 51 Netherlands: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 52 Netherlands: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 53 Netherlands: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 54 Netherlands: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 55 Netherlands: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 56 Russia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 57 Russia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 58 Russia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 59 Russia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 60 Russia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 61 Rest of Europe: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 62 Rest of Europe: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 63 Rest of Europe: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 64 Rest of Europe: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 65 Rest of Europe: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 66 Asia Pacific: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 67 Asia Pacific: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 68 Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 69 Asia Pacific: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 70 Asia Pacific: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 71 China: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 72 China: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 73 China: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 74 China: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 75 China: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 76 India: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 77 India: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 78 India: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 79 India: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 80 India: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 81 Malaysia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 82 Malaysia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 83 Malaysia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 84 Malaysia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 85 Malaysia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 86 Japan: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 87 Japan: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 88 Japan: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 89 Japan: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 90 Japan: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 91 Indonesia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 92 Indonesia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 93 Indonesia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 94 Indonesia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 95 Indonesia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 96 South Korea: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 97 South Korea: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 98 South Korea: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 99 South Korea: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 100 South Korea: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 101 Australia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 102 Australia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 103 Australia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 104 Australia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 105 Australia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 106 Rest of Asia Pacific: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 107 Rest of Asia Pacific: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 108 Rest of Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 109 Rest of Asia Pacific: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 110 Rest of Asia Pacific: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 111 Middle East & Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 112 Middle East & Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 113 Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 114 Middle East & Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 115 Middle East & Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 116 Saudi Arabia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 117 Saudi Arabia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 118 Saudi Arabia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 119 Saudi Arabia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 120 Saudi Arabia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 121 UAE: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 122 UAE: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 123 UAE: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 124 UAE: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 125 UAE: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 126 Israel: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 127 Israel: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 128 Israel: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 129 Israel: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 130 Israel: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 131 South Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 132 South Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 133 South Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 134 South Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 135 South Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 136 Rest of Middle East & Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 137 Rest of Middle East & Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 138 Rest of Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 139 Rest of Middle East & Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 140 Rest of Middle East & Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 141 Latin America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 142 Latin America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 143 Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 144 Latin America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 145 Latin America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 146 Mexico: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 147 Mexico: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 148 Mexico: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 149 Mexico: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 150 Mexico: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 151 Brazil: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 152 Brazil: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 153 Brazil: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 154 Brazil: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 155 Brazil: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 156 Argentina: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 157 Argentina: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 158 Argentina: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 159 Argentina: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 160 Argentina: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 161 Rest of Latin America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 162 Rest of Latin America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 163 Rest of Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 164 Rest of Latin America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 165 Rest of Latin America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • List of Figures:
  • Figure 1. Global AI in Drug Discovery Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Offering
  • Figure 7. Global AI in Drug Discovery Market, by Offering, 2024 & 2034 (USD Million)
  • Figure 8. Market by Technology
  • Figure 9. Global AI in Drug Discovery Market, by Technology, 2024 & 2034 (USD Million)
  • Figure 10. Market by Therapeutic Area
  • Figure 11. Global AI in Drug Discovery Market, by Therapeutic Area, 2024 & 2034 (USD Million)
  • Figure 12. Market by Application
  • Figure 13. Global AI in Drug Discovery Market, by Application, 2024 & 2034 (USD Million)
  • Figure 14. Market by End User
  • Figure 15. Global AI in Drug Discovery Market, by End User, 2024 & 2034 (USD Million)
目次
Product Code: PM1850

The AI in drug discovery market size is expected to reach USD 26,497.79 million by 2034, according to a new study by Polaris Market Research. The report "AI in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Therapeutic Area, By Application, By End User and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa); Segment Forecast, 2025 - 2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The AI in drug discovery market is experiencing rapid growth, due to rapid adoption of technological advancements, increasing healthcare needs, and evolving pharmaceutical industry dynamics. The escalating demand for more efficient and cost-effective drug development processes is driving demand for the AI in drug discovery market. Traditional drug discovery methods are often time-consuming and expensive, with high failure rates during clinical trials. AI offers a solution by accelerating the identification of potential drug candidates, predicting their efficacy and safety, and optimizing clinical trial designs. This reduces the time and cost associated with drug development, thus contributing to the market growth. Furthermore, the growing prevalence of chronic diseases and the increasing need for personalized medicine is driving demand for AI in drug discovery solutions. With rising aging population and increasing incidence of conditions such as cancer, diabetes, and cardiovascular diseases rises, there is a growing need for new and more effective therapies. AI technologies, including machine learning and deep learning, are particularly well-suited to analyzing large datasets and identifying patterns that may not be apparent through traditional methods. This capability enables the development of targeted therapies tailored to individual patient profiles, improving treatment outcomes and reducing adverse effects.

The adoption of AI in drug discovery is being fueled by substantial investments from both private and public sectors. Governments and healthcare organizations worldwide are recognizing the potential of AI to revolutionize the drug discovery process and are investing in research and development initiatives to foster innovation. Moreover, collaborations between AI technology companies and pharmaceutical giants are also on the rise, with partnerships aimed at integrating AI into various stages of drug development. These collaborations are further supported by advancements in computational power, cloud computing, and big data analytics, which provide the necessary infrastructure for AI applications in drug discovery.

AI in Drug Discovery Market Report Highlights

In 2024, the oncology segment accounted for the largest revenue share in the AI in drug discovery market due to the high demand for innovative cancer treatments and the complexity of cancer research, which benefits significantly from AI-driven solutions.

The pharmaceutical & biotechnology companies segment is anticipated to grow at the fastest CAGR due to their increasing adoption of AI technologies to accelerate drug discovery, reduce development costs, and enhance the precision and efficiency of drug development processes.

In 2024, North America accounted for the largest market share in the AI in drug discovery market due to its advanced healthcare infrastructure, high levels of investment in AI research, and the presence of major pharmaceutical and biotechnology companies leveraging AI for drug development.

The Asia Pacific region is expected to grow at the fastest CAGR in the forecast period due to a large and diverse patient population providing valuable data, and supportive government initiatives fostering innovation in drug discovery.

The global key market players include Atomwise Inc., BenevolentAI, Berg Health (Berg Health acquired by BPGbio Inc.), BioSymetrics, Inc., CYCLICA (Acquired by Recursion Pharmaceuticals), Exscientia, GNS Healthcare (the company Rebranded as Aitia), Google (DeepMind), IBM, Insilico Medicine, insitro.

Polaris Market Research has segmented the AI in drug discovery market report based on offering, technology, therapeutic area, application, end user, and region:

By Offering Outlook (Revenue - USD million, 2020-2034)

  • Software
  • Services

By Technology Outlook (Revenue - USD million, 2020-2034)

  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Reinforcement Learning
  • Unsupervised Learning
  • Other Machine Learning Technologies
  • Other Technologies

By Therapeutic Area Outlook (Revenue - USD million, 2020-2034)

  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Disease
  • Metabolic Diseases
  • Infectious Disease
  • Others

By Application Outlook (Revenue - USD million, 2020-2034)

  • Drug optimization & repurposing
  • Preclinical testing
  • Others

By End User Outlook (Revenue - USD million, 2020-2034)

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Research Centers
  • Academic & Government Institutes

By Regional Outlook (Revenue - USD million, 2020-2034)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global AI in Drug Discovery Market Insights

  • 4.1. AI in Drug Discovery Market - Application Snapshot
  • 4.2. AI in Drug Discovery Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Collaboration Between Pharma Companies and AI Providers is Driving Market Growth
      • 4.2.1.2. The Advancements in AI Technology Are Driving the Market Growth.
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data Privacy and Security Concerns are limiting the growth of AI in Drug Discovery market
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. AI in Drug Discovery Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global AI in Drug Discovery Market, by Offering

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • 5.3. Software
    • 5.3.1. Global AI in Drug Discovery Market, by Software, by Region, 2020-2034 (USD Million)
  • 5.4. Services
    • 5.4.1. Global AI in Drug Discovery Market, by Services , by Region, 2020-2034 (USD Million)

6. Global AI in Drug Discovery Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • 6.3. Machine Learning
    • 6.3.1. Global AI in Drug Discovery Market, by Machine Learning, by Region, 2020-2034 (USD Million)
    • 6.3.2. Deep Learning
      • 6.3.2.1. Global AI in Drug Discovery Market, by Deep Learning, by Region, 2020-2034 (USD Million)
    • 6.3.3. Supervised Learning
      • 6.3.3.1. Global AI in Drug Discovery Market, by Supervised Learning, by Region, 2020-2034 (USD Million)
    • 6.3.4. Reinforcement Learning
      • 6.3.4.1. Global AI in Drug Discovery Market, by Reinforcement Learning, by Region, 2020-2034 (USD Million)
    • 6.3.5. Unsupervised Learning
      • 6.3.5.1. Global AI in Drug Discovery Market, by Unsupervised Learning, by Region, 2020-2034 (USD Million)
    • 6.3.6. Other Machine Learning Technologies
      • 6.3.6.1. Global AI in Drug Discovery Market, by Other Machine Learning Technologies, by Region, 2020-2034 (USD Million)
  • 6.4. Other Technologies
    • 6.4.1. Global AI in Drug Discovery Market, by Other Technologies, by Region, 2020-2034 (USD Million)

7. Global AI in Drug Discovery Market, by Therapeutic Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • 7.3. Oncology
    • 7.3.1. Global AI in Drug Discovery Market, by Oncology, by Region, 2020-2034 (USD Million)
  • 7.4. Neurodegenerative Diseases
    • 7.4.1. Global AI in Drug Discovery Market, by Neurodegenerative Diseases, by Region, 2020-2034 (USD Million)
  • 7.5. Cardiovascular Disease
    • 7.5.1. Global AI in Drug Discovery Market, by Cardiovascular Disease, by Region, 2020-2034 (USD Million)
  • 7.6. Metabolic Diseases
    • 7.6.1. Global AI in Drug Discovery Market, by Metabolic Diseases, by Region, 2020-2034 (USD Million)
  • 7.7. Infectious Disease
    • 7.7.1. Global AI in Drug Discovery Market, by Infectious Disease, by Region, 2020-2034 (USD Million)
  • 7.8. Others
    • 7.8.1. Global AI in Drug Discovery Market, by Others, by Region, 2020-2034 (USD Million)

8. Global AI in Drug Discovery Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • 8.3. Drug optimization & repurposing
    • 8.3.1. Global AI in Drug Discovery Market, by Drug optimization & repurposing, by Region, 2020-2034 (USD Million)
  • 8.4. Preclinical testing
    • 8.4.1. Global AI in Drug Discovery Market, by Preclinical testing, by Region, 2020-2034 (USD Million)
  • 8.5. Others
    • 8.5.1. Global AI in Drug Discovery Market, by Others, by Region, 2020-2034 (USD Million)

9. Global AI in Drug Discovery Market, by End User

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • 9.3. Pharmaceutical & Biotechnology Companies
    • 9.3.1. Global AI in Drug Discovery Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Million)
  • 9.4. Contract Research Organizations
    • 9.4.1. Global AI in Drug Discovery Market, by Contract Research Organizations, by Region, 2020-2034 (USD Million)
  • 9.5. Research Centers
    • 9.5.1. Global AI in Drug Discovery Market, by Research Centers, by Region, 2020-2034 (USD Million)
  • 9.6. Academic & Government Institutes
    • 9.6.1. Global AI in Drug Discovery Market, by Academic & Government Institutes, by Region, 2020-2034 (USD Million)

10. Global AI in Drug Discovery Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. AI in Drug Discovery Market Assessment, By Geography, 2020-2034 (USD Million)
  • 10.3. AI in Drug Discovery Market - North America
    • 10.3.1. North America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
    • 10.3.2. North America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
    • 10.3.3. North America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 10.3.4. North America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
    • 10.3.5. North America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.3.7. AI in Drug Discovery Market - U.S.
      • 10.3.7.1. U.S.: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.3.7.2. U.S.: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.3.7.3. U.S.: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.3.7.4. U.S.: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.3.7.5. U.S.: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.3.8. AI in Drug Discovery Market - Canada
      • 10.3.8.1. Canada: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.3.8.2. Canada: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.3.8.3. Canada: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.3.8.4. Canada: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.3.8.5. Canada: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • 10.4. AI in Drug Discovery Market - Europe
    • 10.4.1. Europe: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
    • 10.4.2. Europe: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
    • 10.4.3. Europe: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 10.4.4. Europe: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
    • 10.4.5. Europe: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.6. AI in Drug Discovery Market - UK
      • 10.4.6.1. UK: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.6.2. UK: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.6.3. UK: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.6.4. UK: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.6.5. UK: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.7. AI in Drug Discovery Market - France
      • 10.4.7.1. France: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.7.2. France: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.7.3. France: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.7.4. France: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.7.5. France: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.8. AI in Drug Discovery Market - Germany
      • 10.4.8.1. Germany: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.8.2. Germany: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.8.3. Germany: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.8.4. Germany: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.8.5. Germany: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.9. AI in Drug Discovery Market - Italy
      • 10.4.9.1. Italy: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.9.2. Italy: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.9.3. Italy: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.9.4. Italy: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.9.5. Italy: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.10. AI in Drug Discovery Market - Spain
      • 10.4.10.1. Spain: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.10.2. Spain: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.10.3. Spain: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.10.4. Spain: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.10.5. Spain: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.11. AI in Drug Discovery Market - Netherlands
      • 10.4.11.1. Netherlands: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.11.2. Netherlands: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.11.3. Netherlands: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.11.4. Netherlands: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.11.5. Netherlands: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.12. AI in Drug Discovery Market - Russia
      • 10.4.12.1. Russia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.12.2. Russia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.12.3. Russia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.12.4. Russia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.12.5. Russia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.13. AI in Drug Discovery Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.13.2. Rest of Europe: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.13.3. Rest of Europe: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.13.4. Rest of Europe: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.13.5. Rest of Europe: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • 10.5. AI in Drug Discovery Market - Asia Pacific
    • 10.5.1. Asia Pacific: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
    • 10.5.2. Asia Pacific: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
    • 10.5.3. Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 10.5.4. Asia Pacific: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
    • 10.5.5. Asia Pacific: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.6. AI in Drug Discovery Market - China
      • 10.5.6.1. China: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.6.2. China: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.6.3. China: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.6.4. China: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.6.5. China: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.7. AI in Drug Discovery Market - India
      • 10.5.7.1. India: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.7.2. India: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.7.3. India: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.7.4. India: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.7.5. India: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.8. AI in Drug Discovery Market - Malaysia
      • 10.5.8.1. Malaysia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.8.2. Malaysia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.8.3. Malaysia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.8.4. Malaysia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.8.5. Malaysia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.9. AI in Drug Discovery Market - Japan
      • 10.5.9.1. Japan: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.9.2. Japan: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.9.3. Japan: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.9.4. Japan: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.9.5. Japan: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.10. AI in Drug Discovery Market - Indonesia
      • 10.5.10.1. Indonesia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.10.2. Indonesia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.10.3. Indonesia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.10.4. Indonesia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.10.5. Indonesia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.11. AI in Drug Discovery Market - South Korea
      • 10.5.11.1. South Korea: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.11.2. South Korea: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.11.3. South Korea: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.11.4. South Korea: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.11.5. South Korea: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.12. AI in Drug Discovery Market - Australia
      • 10.5.12.1. Australia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.12.2. Australia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.12.3. Australia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.12.4. Australia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.12.5. Australia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.13. AI in Drug Discovery Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.13.2. Rest of Asia Pacific: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.13.3. Rest of Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.13.4. Rest of Asia Pacific: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.13.5. Rest of Asia Pacific: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • 10.6. AI in Drug Discovery Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
    • 10.6.2. Middle East & Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
    • 10.6.3. Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 10.6.4. Middle East & Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
    • 10.6.5. Middle East & Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.6.6. AI in Drug Discovery Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.6.6.2. Saudi Arabia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.6.6.3. Saudi Arabia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.6.6.4. Saudi Arabia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.6.6.5. Saudi Arabia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.6.7. AI in Drug Discovery Market - UAE
      • 10.6.7.1. UAE: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.6.7.2. UAE: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.6.7.3. UAE: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.6.7.4. UAE: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.6.7.5. UAE: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.6.8. AI in Drug Discovery Market - Israel
      • 10.6.8.1. Israel: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.6.8.2. Israel: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.6.8.3. Israel: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.6.8.4. Israel: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.6.8.5. Israel: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.6.9. AI in Drug Discovery Market - South Africa
      • 10.6.9.1. South Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.6.9.2. South Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.6.9.3. South Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.6.9.4. South Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.6.9.5. South Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.6.10. AI in Drug Discovery Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.6.10.2. Rest of Middle East & Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.6.10.3. Rest of Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.6.10.4. Rest of Middle East & Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.6.10.5. Rest of Middle East & Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • 10.7. AI in Drug Discovery Market - Latin America
    • 10.7.1. Latin America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
    • 10.7.2. Latin America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
    • 10.7.3. Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 10.7.4. Latin America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
    • 10.7.5. Latin America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.7.6. AI in Drug Discovery Market - Mexico
      • 10.7.6.1. Mexico: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.7.6.2. Mexico: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.7.6.3. Mexico: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.7.6.4. Mexico: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.7.6.5. Mexico: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.7.7. AI in Drug Discovery Market - Brazil
      • 10.7.7.1. Brazil: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.7.7.2. Brazil: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.7.7.3. Brazil: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.7.7.4. Brazil: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.7.7.5. Brazil: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.7.8. AI in Drug Discovery Market - Argentina
      • 10.7.8.1. Argentina: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.7.8.2. Argentina: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.7.8.3. Argentina: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.7.8.4. Argentina: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.7.8.5. Argentina: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.7.9. AI in Drug Discovery Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.7.9.2. Rest of Latin America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.7.9.3. Rest of Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.7.9.4. Rest of Latin America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.7.9.5. Rest of Latin America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Atomwise Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. BenevolentAI
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Berg Health
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. BioSymetrics, Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. CYCLICA
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Exscientia
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. GNS Healthcare
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Google
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. IBM
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Insilico Medicine
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. insitro
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development